Cite
HARVARD Citation
Stern, S. et al. (2018). Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulation. Journal of medical economics. pp. 27-37. [Online].